New nasal COVID booster shows promise in early trial
NCT ID NCT06441968
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 34 times
Summary
This early-stage trial tested a new COVID-19 booster vaccine given as a nasal spray. The goal was to see if it is safe and how well it boosts the immune system. The study involved 60 healthy adults who had already received the standard COVID-19 shots. Researchers monitored side effects and measured antibody levels in the blood and nose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-3411, United States
-
NYU Grossman Long Island School of Medicine - Vaccine Center
Mineola, New York, 11501, United States
-
The Hope Clinic of Emory University
Decatur, Georgia, 30030-1705, United States
Conditions
Explore the condition pages connected to this study.